Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 11:12 PM
Ignite Modification Date:
2025-12-26 @ 11:12 PM
NCT ID:
NCT02268812
Eligibility Criteria:
Inclusion Criteria
Patients will be eligible to enroll onto the registry if they have given informed consent and meet the following criteria:
* Patient's physician has deemed that the initiation/switch of intrathecal analgesia appropriate, or patient is presently utilizing ziconotide (Prialt)
* Patient has a diagnosis of severe, chronic pain for which intrathecal infusion is indicated
* Patient is at least 18 years of age at time of study entry
All patients starting ziconotide (Prialt) should comply with the indications and warnings in the current approved version of the Summary of Product Characteristics (SmPC).
Exclusion Criteria
Patients who meet any of the following criteria will not be eligible to enroll in the registry:
* Patient is a pregnant or lactating female
* Patient is receiving intrathecal chemotherapy
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02268812
Study Brief:
Protocol Section:
NCT02268812